X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs BIOCON - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA BIOCON ABBOTT INDIA/
BIOCON
 
P/E (TTM) x 38.0 41.0 92.5% View Chart
P/BV x 9.8 7.1 137.6% View Chart
Dividend Yield % 0.7 0.2 433.3%  

Financials

 ABBOTT INDIA   BIOCON
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
BIOCON
Mar-18
ABBOTT INDIA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs6,1101,188 514.3%   
Low Rs3,996305 1,310.2%   
Sales per share (Unadj.) Rs1,552.268.7 2,258.7%  
Earnings per share (Unadj.) Rs188.87.6 2,500.2%  
Cash flow per share (Unadj.) Rs196.414.0 1,406.0%  
Dividends per share (Unadj.) Rs55.001.00 5,500.0%  
Dividend yield (eoy) %1.10.1 812.5%  
Book value per share (Unadj.) Rs796.686.3 922.6%  
Shares outstanding (eoy) m21.25600.00 3.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.310.9 30.0%   
Avg P/E ratio x26.898.9 27.1%  
P/CF ratio (eoy) x25.753.4 48.1%  
Price / Book Value ratio x6.38.6 73.4%  
Dividend payout %29.113.2 220.0%   
Avg Mkt Cap Rs m107,376447,900 24.0%   
No. of employees `0003.36.1 54.0%   
Total wages/salary Rs m3,9379,311 42.3%   
Avg. sales/employee Rs Th9,929.36,705.8 148.1%   
Avg. wages/employee Rs Th1,185.11,514.2 78.3%   
Avg. net profit/employee Rs Th1,207.7736.9 163.9%   
INCOME DATA
Net Sales Rs m32,98541,234 80.0%  
Other income Rs m1,1702,062 56.7%   
Total revenues Rs m34,15543,296 78.9%   
Gross profit Rs m5,2458,291 63.3%  
Depreciation Rs m1623,851 4.2%   
Interest Rs m38615 6.2%   
Profit before tax Rs m6,2155,887 105.6%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2031,569 140.4%   
Profit after tax Rs m4,0124,531 88.5%  
Gross profit margin %15.920.1 79.1%  
Effective tax rate %35.426.7 133.0%   
Net profit margin %12.211.0 110.7%  
BALANCE SHEET DATA
Current assets Rs m22,65541,486 54.6%   
Current liabilities Rs m6,68121,413 31.2%   
Net working cap to sales %48.448.7 99.5%  
Current ratio x3.41.9 175.0%  
Inventory Days Days6564 101.3%  
Debtors Days Days2994 31.0%  
Net fixed assets Rs m83550,661 1.6%   
Share capital Rs m2133,000 7.1%   
"Free" reserves Rs m16,71548,808 34.2%   
Net worth Rs m16,92851,808 32.7%   
Long term debt Rs m017,898 0.0%   
Total assets Rs m24,16299,897 24.2%  
Interest coverage x163.710.6 1,548.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.40.4 330.7%   
Return on assets %16.85.2 325.4%  
Return on equity %23.78.7 271.0%  
Return on capital %36.99.6 383.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36912,058 3.1%   
Fx outflow Rs m3,8077,348 51.8%   
Net fx Rs m-3,4384,710 -73.0%   
CASH FLOW
From Operations Rs m1,5276,621 23.1%  
From Investments Rs m-2,148-6,840 31.4%  
From Financial Activity Rs m-1,024-2,397 42.7%  
Net Cashflow Rs m-1,646-2,612 63.0%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 75.0 20.6 364.1%  
Indian inst/Mut Fund % 7.9 8.4 94.0%  
FIIs % 0.1 10.7 0.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 19.9 85.9%  
Shareholders   18,270 109,995 16.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  MERCK  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 18, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS